Heart progenitor cells (green) can be induced to become mature cardiomyocytes (one shown in yellow) using a peptide prodder; each cell is approximately 20 μm wide. Credit: Paul Riley
A broken heart may one day be able to mend itself with the help of a small peptide that prods undifferentiated heart cells to morph into new heart muscle, according to a report in Nature (DOI: 10.1038/nature10188). Heart attacks currently lead to permanent heart damage, but the discovery by Paul R. Riley of University College London and colleagues sets the stage for scientists to develop a treatment that could enable hearts to produce new cardiomyocytes and self-repair the damage. Riley’s team worked with a peptide called thymosin β4 that had previously been shown to help outer-layer heart cells cope with injury. The researchers found that thymosin β4 induced outer-layer progenitor cells in mice to differentiate into cardiomyocytes that could “structurally and functionally integrate with resident muscle.” The putative peptide drug is unlikely to land in the clinic, however, unless scientists can get it to produce greater quantities of cardiomyocytes, they note.
Chemical & Engineering News ISSN 0009-2347 Copyright © 2026 American Chemical Society
Sign in to get more C&EN.
Access more articles right now by creating an ACS ID and a free Community Associate account. Alongside more articles each month, this will enable you to save articles for later and futher personalize your experience with C&EN.
Already a Subscriber? Sign In
Want to upgrade to a paid account and get full access to C&EN?
See all our subscription options